KIDSORTHOPEDIATRICS CORP同业对比
ORTHOPEDIATRICS CORP 与SIC 3841 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KIDS本股 | $809M#6 | — | 2.4x#4 | 3.4x#7 | 15.4%#10 | -4.8%#11 | -16.6%#9 | -11.7%#6 | -8.7%#1 | 4#8 | — | — |
| PRCT | $1.1B#1 | — | 3.4x#7 | 3.7x#8 | 37.2%#4 | -4.5%#10 | -33.7%#12 | -0.0%#4 | -63.4%#9 | 2#10 | -42.4%#6 | — |
| ATEC | $1.1B#2 | — | — | 1.5x#3 | 25.0%#6 | 11.6%#9 | -10.7%#5 | — | -17.7%#5 | 6#3 | -62.0%#8 | — |
| IART | $1.0B#3 | 79.4x#2 | 1.0x#1 | 0.6x#1 | 1.5%#13 | -7389.9%#14 | -30.2%#11 | -48.5%#11 | -32.6%#8 | 6#3 | 17.5%#5 | — |
| SIBN | $1.0B#4 | — | 5.6x#9 | 5.1x#10 | 20.2%#7 | 38.8%#2 | -11.1%#6 | -10.4%#5 | -12.0%#2 | 6#3 | 51.5%#3 | — |
| BBNX | $830M#5 | — | 2.1x#2 | 8.3x#13 | 53.9%#3 | -33.7%#13 | -71.5%#14 | -18.2%#7 | — | — | -44.9%#7 | — |
| TCMD | $560M#7 | 24.3x#1 | 2.5x#5 | 1.7x#5 | 12.5%#11 | 12.5%#8 | 8.9%#2 | 8.4%#2 | — | — | 58.4%#2 | — |
| SGHT | $530M#8 | — | 10.0x#12 | 6.9x#12 | -3.1%#14 | 25.4%#4 | -48.0%#13 | -72.6%#12 | -266.6%#10 | 5#6 | 88.7%#1 | — |
| DCTH | $500M#9 | 720.0x#3 | 4.1x#8 | 5.9x#11 | 129.1%#1 | 110.2%#1 | 0.8%#3 | 2.2%#3 | — | 8#1 | 50.9%#4 | — |
| ANGO | $500M#10 | — | 3.0x#6 | 1.6x#4 | 9.5%#12 | -8.1%#12 | -12.5%#7 | -22.4%#9 | -15.7%#4 | 5#6 | — | — |
| SSII | $457M#13 | — | 8.6x#11 | 10.8x#14 | 105.7%#2 | 36.7%#3 | -19.3%#10 | -22.7%#10 | -20.1%#6 | — | — | — |
| MDXG | $462M#11 | — | 2.2x#3 | 1.1x#2 | 20.0%#8 | 14.5%#7 | 15.3%#1 | 23.0%#1 | — | 7#2 | — | — |
| CERS | $458M#12 | — | 6.1x#10 | 2.0x#6 | 16.1%#9 | 25.3%#5 | -3.7%#4 | -20.6%#8 | -13.7%#3 | — | — | — |
| NPCE | $425M#14 | — | 35.7x#13 | 4.2x#9 | 25.1%#5 | 20.9%#6 | -16.3%#8 | -180.6%#13 | -28.0%#7 | 4#8 | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-03。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议